Progress and Challenges in Using Oral Cholera Vaccines to Control Outbreaks: The Médecins Sans Frontières Experience. [PDF]
J Infect Dis, 2018 The use of oral cholera vaccine (OCV) has increased since 2011, when Shanchol, the first OCV suitable for large-scale use, became available. Médecins Sans Frontières considers OCVs an essential cholera outbreak control tool and has contributed to ...
Ciglenecki I +5 more
europepmc +2 more sources
The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis. [PDF]
PLoS Negl Trop Dis, 2018 Background Cholera remains an important public health problem in major cities in Bangladesh, especially in slum areas. In response to growing interest among local policymakers to control this disease, this study estimated the impact and cost ...
Khan AI +11 more
europepmc +2 more sources
Allocation of Oral Cholera Vaccines in Africa [PDF]
VaccinesObjectives: In this study, we examine the allocation of oral cholera vaccines (OCVs) across 25 African countries between 2013 and 2019. Methods: We constructed a dataset combining cholera outbreaks and requests, decisions, and deliveries of OCVs from the
Elisa M. Maffioli, Yutong Lu
doaj +2 more sources
Current and future cholera vaccines
Vaccine, 2020 Cholera remains a major global public health problem that is primarily linked to insufficient access to safe water and proper sanitation. Oral Cholera Vaccine (OCV) has been recommended as an additional public health tool along with WASH in cholera endemic countries and in areas at risk for outbreaks.
Hanif Shaikh +3 more
openaire +4 more sources
Oral killed cholera vaccines for preventing cholera. [PDF]
Cochrane Database Syst RevCholera causes acute watery diarrhoea and death if not properly treated. Outbreaks occur in areas with poor sanitation, including refugee camps. Several vaccines have been developed and tested over the last 50 years. This is an update of a Cochrane review, originally published in 1998, which explored the effects of all vaccines for preventing cholera ...
Saif-Ur-Rahman KM +4 more
europepmc +3 more sources
Overprescription of cholera vaccine. [PDF]
BMJ, 1990 Vikki Usherwood, Tim Usherwood
+12 more sources
Review of oral cholera vaccines: efficacy in young children
Infection and Drug Resistance, 2011 Cristina Masuet Aumatell1, JM Ramon Torrell1, Jane N Zuckerman21International Health Centre, Preventive Medicine Department, Bellvitge Hospital, L'Hospitalet de Llobregat, Barcelona, Spain; 2World Health Organization Collaborating Centre for ...
Masuet Aumatell C +2 more
doaj +2 more sources
Vaccination strategies to combat an infectious globe: Oral cholera vaccines
Journal of Global Infectious Diseases, 2011 Cholera is a substantial health burden in many countries in Africa and Asia, where it is endemic. It is as well responsible for ongoing epidemics in sub-Saharan Africa which are becoming greater in terms of frequency, extension, and duration.
Rosa M López-Gigosos +3 more
doaj +2 more sources
Prospective observational studies to provide confidence in the protection conferred by newer generation, inactivated oral cholera vaccines: a proposal [PDF]
EClinicalMedicineSummary: Inactivated oral cholera vaccines (OCVs) are a cornerstone of international efforts to control cholera, and are currently deployed from a global stockpile for the control of epidemics and endemic hotspots, as well as for humanitarian emergencies.
John Clemens +2 more
doaj +2 more sources
Critical analysis of compositions and protective efficacies of oral killed cholera vaccines. [PDF]
Clin Vaccine Immunol, 2014 Two cholera vaccines, sold as Shanchol and Dukoral, are currently available. This review presents a critical analysis of the protective efficacies of these vaccines. Children under 5 years of age are very vulnerable to cholera and account for the highest
Kabir S.
europepmc +2 more sources